Numerous large studies have investigated the clinical significance of KRAS and BRAF mutations in CRC [4-6, 27-31], but the specific role of KRAS and BRAF mutations in colorectal carcinogenesis remains unclear. Here, KRAS is linked to colorectal carcinoma.